Jubilant Biosys has entered into drug discovery
collaboration with Mnemosyne Pharmaceutical Inc to develop molecules
for treating mental disorders resulting from diseases of the nervous
system.
The alliance shall initially span a period of two years and may be extended on mutual consent across other therapeutic programs as well.
The alliance shall initially span a period of two years and may be extended on mutual consent across other therapeutic programs as well.
No comments:
Post a Comment